General Infectious Disease
WHO Global Arborvirus Initiative: Where do Infectious Disease Providers Play a Role?
- Fidaxomicin Is Superior to Vancomycin for Clostridioides difficile Infection
- Psychiatric Risks Subside Before Neurologic Risks After COVID-19
- Presence of Particulate Prompts Recall of Acyclovir Intravenous Product
- Chronic Liver Disease Mortality Rates Increased During COVID-19 Pandemic
- Norovirus Outbreaks Have Increased to Prepandemic Levels
- USPSTF Recommends Syphilis Screening for At-Risk Persons
- Bivalent mRNA-1273.214 Elicits Better Response Against Omicron
- Persistent Pulmonary Dysfunction Seen in Children After COVID-19
- Persistent Bacteremia Is Rare in Non-Staphylococcal Infective Endocarditis
- HPV Vaccine in Patients With Palmoplantar Warts
- Are Serum Sclerostin Levels Linked to Body Composition, Lung Function in COPD?
- Pfizer, Moderna Seek Approval of New COVID-19 Boosters for Children
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
ADT May Increase Risk of Death From Cardiovascular Disease in Prostate Cancer
Immunocompromised Patients With COVID-19 and Risk for ICU Admission, Mortality
Ustekinumab, Adalimumab Highly Efficacious for Treating Moderate to Severe Crohn Disease
COVID-19 Treatment: WHO Releases 11th Update to Living Guideline
Olfaction Impairment Patterns: COVID-19 vs Mild Cognitive Impairment
